GE HealthCare Technologies Inc. Common Stock vs Lowe`s Companies Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Lowe`s Companies Inc trades at $191.31 (market cap $105.65B). The key difference: Lowe`s Companies Inc is far larger — about 3.4× GE HealthCare Technologies Inc. Common Stock's market cap, and Lowe`s Companies Inc pays the higher dividend (2.66%). Which is the better fit depends on your goals.
| GEHC | LOW | |
|---|---|---|
Market Cap | $30.93B | $105.65B |
Volume | 5,033,451 | 1,711,895 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $287.39 |
52-Week Low | $59.48 | $179.50 |
Enterprise Value | $39.39B | $144.50B |
Dividend Yield | 0.23% | 2.66% |
Typical Hold Time | — | 98 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Lowe's (LOW) trades at $188.77, up 1.72% with recent earnings beats but faces bearish technical signals. The stock shows solid fundamentals with a P/E of 15.95 and net margin of 7.35%, though revenue declined to $83.67B in 2025. Recent news highlights drone delivery innovation with DoorDash and Alphabet, while analyst consensus remains strongly bullish with a $244.09 price target representing 29% upside potential.
LOW presents a value opportunity with attractive valuation metrics and consistent dividend payments, but faces headwinds from slowing home improvement demand and elevated debt levels. The stock's negative shareholder equity and competitive pressure from Home Depot require careful monitoring, though institutional support remains strong with 60.79% buy ratings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →